However, a notable finding is the occurrence of circulating protein features centered on signatures of oncogenic MYC and YAP1 that were elevated in plasmas of cases at the time-of-diagnosis and at the pre-clinical stage of SCLC. The gene discussed is MYC; the disease is small cell lung carcinoma.